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Abstract
Many host and bacterial factors contribute to the development of different Escherichia coli extra-intestinal infections. The aim of this
study was to evaluate the roles of host and bacterial factors in different extra-intestinal E. coli infections. A total of 221 E. coli isolates
collected from urine, bile and peritoneal ﬂuid were included in this retrospective study. Four main phylogenetic groups of E. coli, 14
genetic determinants, static bioﬁlm formation and antimicrobial resistance data were assessed, as well as the immunological status of
the hosts. Group B2 was the most common phylogenetic group (30%), especially in cases of asymptomatic bacteriuria (ABU), urinary
tract infection (UTI), acute appendicitis/gastrointestinal perforation, and spontaneous bacterial peritonitis (SBP), and was associated with
elevated prevalence of papG III, ﬁmH, sfa, iha, hlyA, cnf1, ompT and usp. Phylogenetic group A was most common in the isolates from
asymptomatic bacteriocholia, biliary tract infection, and peritoneal dialysis (PD)-related peritonitis. There was similarity with respect to
both phylogenetic groups and virulence factors in strains from faeces and ABU, and in strains from faeces and SBP/PD-related peritoni-
tis. Host characteristics were important in patients with ABU, UTI, and SBP/PD-related peritonitis. Immunocompetence of hosts was
associated with a relatively high prevalence of papG II, afa and iha, and relatively low antimicrobial resistance to ﬂuoroquinolones. This
study demonstrates that, in most E. coli extra-intestinal infections, phylogenetic group B2 was predominant and was more virulent than
the three other phylogenetic groups in the Taiwanese population studied. The diverse patterns of host and bacterial factors demon-
strate that there were different host and bacterial factors dominating in different extra-intestinal E. coli infections.
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Introduction
Escherichia coli is a normal inhabitant of the gut ﬂora and is
also the Gram-negative bacillus most frequently isolated in
different human infections. Many bacterial traits of E. coli and
host factors contribute to the development of different
E. coli extra-intestinal infections and affect the clinical out-
come [1–5].
Four main phylogenetic groups of E. coli, A, B1, B2, and D,
were identiﬁed using multilocus enzyme electrophoresis [6].
The E. coli strains responsible for urinary tract infections
(UTIs) and other extra-intestinal infections belong mainly to
phylogenetic groups B2 and D [7–10]. The virulence factors
of extra-intestinal pathogenic E. coli include diverse adhesins,
toxins, siderophores, polysaccharide coatings, proteases, and
invasins [11–13]. These virulence factors can facilitate coloni-
zation and invasion of the host, and/or serve to avoid or dis-
rupt host defence mechanisms. Bioﬁlm growth increases the
resistance of bacteria to the immune system, decreases anti-
biotic efﬁcacy, and disperses planktonic cells to distant body
sites. The role of bioﬁlm formation in different human infec-
tions has been established [14–16]. Antimicrobial resistance
of E. coli is increasing in Taiwan [17,18]. This complicates the
treatment of infections and contributes to adverse clinical
outcomes. The link between antimicrobial resistance and
bacterial virulence remains to be elucidated [19,20].
There is debate about the roles of host and bacterial fac-
tors and their relationship in different infections. In some
high-risk individuals, the patient’s underlying condition is
more important than microbial factors in determining the
outcome [21]. A previous study of E. coli-related UTIs and
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acute cholangitis demonstrated that biliary tract obstruction,
not virulence factors of E. coli, is the most important factor
in acute cholangitis leading to the development of E. coli
bacteraemia. Both E. coli virulence factors and host factors
contributed to the development of E. coli bactaeremia in
upper UTIs [3].
The aim of this study was to examine and compare the
prevalence and distribution of phylogenetic traits, virulence
factors, ability to form bioﬁlm and antimicrobial resistance of
the common E. coli strains causing extra-intestinal coloniza-
tion and infection.
Materials and Methods
Patients and bacterial strains
From January 2004 to December 2006, 221 E. coli isolates
from urine, bile or peritoneal ﬂuid were collected from
patients at National Cheng Kung University Hospital in
Taiwan. Thirty E. coli isolates from the faecal ﬂora of healthy
individuals were also included. Medical records were
reviewed. Only one isolate per patient was accepted. Asymp-
tomatic bacteriuria (ABU) was deﬁned as bacterial coloniza-
tion of urine in the absence of clinical symptoms. Diagnostic
criteria for lower UTI included urgency and frequency of uri-
nation, dysuria, and/or lower abdominal pain with normal
body temperature. Diagnostic criteria for upper UTI included
fever (body temperature ‡38.3C), ﬂank pain, and/or tender-
ness of the costovertebral angle. An inclusion criterion for
upper and lower UTI was a quantitative culture of
‡105 CFU/mL for E. coli isolated from midstream urine or
catheter. Culture of E. coli from bile was obtained from the
gall bladder or the common bile duct through a percutane-
ous catheter or endoscopic drainage. The diagnostic criteria
for biliary tract infection (BTI) included fever, abdominal pain
in the right upper quadrant, and/or jaundice, with imaging
demonstrating the presence of acute cholecystitis or acute
cholangitis. Otherwise, a positive culture of E. coli in bile in
the absence of clinical symptoms was considered to be
colonization (i.e. bacteriocholia). E. coli from peritoneal ﬂuid
was obtained from aspirates of peritoneal ﬂuid during sur-
gery for acute appendicitis or gastrointestinal perforation,
from ascites of patients with liver cirrhosis-related spontane-
ous bacterial peritonitis (SBP), or from dialysate of patients
with peritoneal dialysis (PD)-related peritonitis. Susceptibility
of E. coli strains, investigated using the disk diffusion method
and interpretive criteria according to the CLSI guidelines of
2006, was determined for ampicillin, gentamicin, cefazolin,
second-generation cephalosporins (cefuroxime, cefoxitin, or
cefmetazole), third-generation cephalosporins (cefotaxime,
ceftriaxone, ceftazidime, ceﬁxime, or cefpodoxime), fourth-
generation cephalosporins (cefepime or cefpirome), and
ﬂuoroquinolones (ciproﬂoxacin, levoﬂoxacin, or lomeﬂoxa-
cin). Intermediate susceptibility was interpreted as resistance.
Resistance to any of the second-generation cephalosporins
was interpreted as resistance to all second-generation
cephalosporins. The same interpretation criterion was
applied to the third-generation and fourth-generation cepha-
losporins and the ﬂuoroquinolones, respectively.
A compromised host was deﬁned as having any of the fol-
lowing conditions: diabetes mellitus, malignancy (three
patients receiving chemotherapy were included), liver
cirrhosis, or autoimmune disease (systemic lupus erythemat-
osus or rheumatoid arthritis). There were: 79 strains from
urine (42 cases of ABU and 37 of UTI (28 lower and nine
upper UTIs)); 67 strains from bile (20 cases of asymptomatic
bacteriocholia (ABC) and 47 of BTI (11 of acute cholecystitis
and 36 of acute cholangitis)); and 75 strains from peritoneal
ﬂuid (36 cases of acute appendicitis, eight of gastrointestinal
perforation, 17 of SBP, and 14 of PD-related peritonitis).
Among the 20 E. coli isolates in the ABC group, 17 were
obtained from patients with obstructive jaundice due to cho-
ledocholithiasis (n = 12), cholangiocarcinoma (n = 2), ampul-
lary carcinoma (n = 2), or pancreatic cancer (n = 1), and
three were isolates from patients receiving elective cholecys-
tectomy. Stool specimens were collected from 30 healthy
individuals (15 men and 15 women, age 34 ± 10 years) who
had not received any antimicrobial agent during the preced-
ing 6 months. The E. coli strains from stool, urine, bile and
peritoneal ﬂuid were identiﬁed using standard methods [22],
and stored in 20% glycerol at )70C until used in all subse-
quent analyses.
Phylogenetic analysis and detection of E. coli virulence
determinants
The phylogenetic grouping of the E. coli isolates was deter-
mined by a PCR-based method developed by Clermont et al.
[23]. The presence of chuA and yjaA and of the DNA fragment
TSPE4.C2 was examined, and E. coli isolates were assigned to
one of the four main phylogenetic groups (A, B1, B2, and D).
These results were further conﬁrmed using a dot blot assay.
Fifty microlitres of an E. coli DNA extract was pipetted onto a
nitrocellulose membrane (in a dot blot device), together with
an equal volume of 0.2 M NaOH added to the DNA sample.
The DNA was incubated at room temperature for 10 min, and
the membrane washed with 50 lL of buffer (0.5 M Tris-HCl
(pH 7.5), 1.5 M NaCl) per well; vacuum was applied for
30 min. The DNA was cross-linked using a UV cross-linker
device (Amersham Biosciences, Piscataway, NJ, USA), and the
membrane rinsed with 2 · SSC buffer (30 mM sodium citrate,
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pH 7.0, 0.3 M NaCl). After hybridization with a DNA probe at
60C for 60 min, the membrane was exposed overnight to ﬁlm
for autoradiography.
Fourteen virulence genes of E. coli were detected using
PCR. Primer pairs speciﬁc for the three PapG adhesin genes
(papG class I–III) of P-ﬁmbriae and genes for type 1 ﬁmbrial
adhesins (ﬁmH), S-/F1C-ﬁmbriae (sfa/foc), aﬁmbrial adhesins
(afa), iron-regulated gene A homologue adhesin (iha), haem-
olysin (hlyA), cytotoxic necrotizing factor 1 (cnf1), catecho-
late siderophore receptor (iroN), aerobactin receptor (iutA),
outer membrane protease T (ompT) and uropathogenic spe-
ciﬁc protein (usp) have been described previously [24–28].
The extraction of bacterial DNA and DNA ampliﬁcation
were done as described previously [24]. PCRs were carried
out in duplicate, and positive and negative control strains for
the traits of interest were included in each assay. The nucle-
otide sequence of the PCR product for each virulence gene
was determined using an automated sequencing system
(3100 Genetic Analyzer; ABI Prism, Foster, CA, USA) to
conﬁrm the ampliﬁcation products.
Distribution patterns of phylogeny and virulence factors
between two groups were called ‘different’ when there was
a signiﬁcant difference in one or more of four phylogenetic
groups and in two or more of 14 virulence genes, respec-
tively. Otherwise, the patterns were called ‘similar’.
Bioﬁlm formation assays
An E. coli culture was placed in a polystyrene microtitre plate
(Costar, Corning, NY, USA) and grown overnight in Luria–
Bertani (LB) broth at 37C. The plate was then washed with
1 · phosphate-buffered saline (PBS) and resuspended in
1 mL of LB broth. Subcultures containing 10 lL of suspen-
sion medium and 190 lL of LB broth were grown in new
polystyrene 96-well plates, and incubated at 37C for 48 h
without shaking. After removal of bacterial supernatants and
two washes with 200 lL of 1 · PBS, the bioﬁlm was stained
with 200 lL of 0.1% crystal violet (CV) solution for 15 min.
After two subsequent washes with 200 lL of 1 · PBS, the
surface-bound CV was extracted by the addition of 200 lL
of 0.3% acetic acid, and the concentration of CV was deter-
mined by the optical density reading at 590 nm [16,29–31].
The bioﬁlm formation assay was carried out in triplicate. Bio-
ﬁlm formation was also estimated according to the method
described by Narisawa et al. [32].
Statistical analysis
The Pearson chi square test or Fisher’s exact test (two-tailed)
was used for categorical variables, whereas the Wilcoxon
rank sum test was used for continuous variables between any
two groups. A p-value <0.05 was considered to be statistically
signiﬁcant. All statistical analyses were performed using JMP
software (SAS Institute Inc., Cary, NC, USA).
Results
Eighty-two (37%) hosts were compromised. Phylogenetic
group B2 was the most common group (30%) overall among
the E. coli isolates from extra-intestinal infections. The overall
antimicrobial resistance rate was 63% for ampicillin, c. 20% for
gentamicin, cefazolin, and second-generation and third-genera-
tion cephalosporins, and 21% for ﬂuoroquinolones (Table 1).
The distribution of host and bacterial characteristics in
relation to the source of E. coli strains is shown in Table 2.
Patients in the appendicitis/gastrointestinal perforation group
were younger than those in the UTI and BTI groups. The
prevalence of female gender, diabetes mellitus and malig-
nancy was greater in the UTI group (80%, 34%, and 24%,
respectively). The prevalence of host-compromising factors
was greater in the urine (53%) and SBP/PD-related peritoni-
tis (77%) groups. The most common phylogenetic group in
the faeces from healthy individuals was phylogenetic
group B2 (53%) (data not shown).
Phylogenetic group B2 was also the most common phylo-
genetic group in the ABU, UTI, appendicitis/gastrointestinal
TABLE 1. Host and bacterial characteristics
Characteristic Total (n = 221)
Age (years): 61 ± 19
Gender (female) 131 (59)
Host-compromising factor
Diabetes mellitus 37 (17)
Malignancy 31 (14)
Liver cirrhosis 19 (9)
Autoimmune disease 4 (2)
Any one of the above factors 82 (37)
Source of Escherichia coli strains
Urine, overall 79
Asymptomatic bacteriuria 42
Urinary tract infection 37
Bile, overall 67
Asymptomatic bacteriocholia 20
Biliary tract infection 47
Peritoneal ﬂuid—overall 75
Acute appendicitis and gastrointestinal perforation 44
Spontaneous bacterial peritonitis 17
Peritoneal dialysis-related peritonitis 14
Phylogenetic group
A 56 (25)
B1 53 (24)
B2 67 (30)
D 45 (20)
Antimicrobial resistance
Ampicillin 139 (63)
Gentamicin 40 (18)
Cefazolin 46 (21)
Second-generation cephalosporins 42 (19)
Third-generation cephalosporins 38 (17)
Fourth-generation cephalosporins 10 (5)
Fluoroquinolones 47 (21)
Values are presented as mean ± standard deviation or number (%) unless other-
wise indicated.
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perforation and SBP/PD peritonitis groups. Phylogenetic
group A was the most common phylogenetic group in the
ABC and BTI groups. Among the 14 virulence factors, the
prevalence of papG II, afa, iroN, ompT and usp was relatively
low in faecal isolates from healthy individuals (3%, 0%, 13%,
37%, and 20%), and the prevalence of iha, iutA and usp was
relatively low in the bile group. The iroN and ompT genes
were more common in the UTI isolates, papG II was most
common (55%) in the appendicitis/gastrointestinal perfora-
tion isolates, and papG III was least common (£6%) in the
UTI, ABC and SBP/PD-related peritonitis isolates.
The capacity for bioﬁlm formation was greater in the fae-
cal isolates from healthy individuals than in isolates from
urine, bile and peritoneal ﬂuid from patients. There was no
signiﬁcant difference in antimicrobial resistance among the
isolates in the three latter groups (data not shown).
The distribution of phylogenetic groups and virulence fac-
tors among different extra-intestinal E. coli colonization and
TABLE 2. Host and bacterial characteristics in relation to the source of Escherichia coli strains
Characteristic
Bacterial source
Urine (n = 79) Bile (n = 67) Peritoneal ﬂuid (n = 75)
ABU
(n = 42)
UTI
(n = 37)
ABC
(n = 20)
BTI
(n = 47)
Appendicitis/GI
perforation (n = 44)
SBP/PD-related
peritonitis (n = 31)
Age (years) 66 ± 17a 63 ± 18a 65 ± 15a 69 ± 11a,b 50 ± 24c,d,e 55 ± 17a,d
Gender (female) 81e 78f 50 43c 48c 55
Host-compromising factor
Diabetes mellitus 45a,b 21e 15 8 0c 9
Malignancy 23e 24e 20f 10 2c 6
Liver cirrhosis 2 2 0 0 0 54a,d,g,h
Autoimmune disease 0 2 0 0 0 9
Any one of the above factors 61a 43a 35i 17b,f 2g,j 77a,c,d,h
Phylogenetic group
A 7b 27 40 36 18 32
B1 19 19 30 36f 25 13j
B2 43 38 15e 13b,i 34j 35j
D 31 16 15 15 23 19
Adhesin
papG I 0 0 0 0 0 0
papG II 16 24f 15 21f 55a,c,k 32e
papG III 19b 3 5 21b,f 18a,b 6
ﬁmH 95 89 85 87 95 90
sfa 11 0 5 10 6 6
foc 0 8 10 0 2 0
afa 4b 21e 5 19f 38a 6l
iha 19 24 5 4c,f 29k 19
Toxin
hlyA 14 16 30f 12 9 19
cnf1 14 10 15 4 4 6
Siderophore
iroN 35 54i 30 27b 27b 35
iutA 54 62 35 29c 56j 70m
Miscellaneous
ompT 73e 81i 70f 44n 47c 54b
usp 54e 54e 35 19c 40j 38
Bioﬁlm formation
(OD590 mm)*
0.066 (0.000–1.526) 0.053 (0.000–0.814)f 0.084 (0.000–0.389) 0.014 (0.000–0.663)a 0.033 (0.000–0.321)a 0.023 (0.000–0.471)i
Values are presented as mean ± standard abbreviation or percentage unless otherwise indicated.
ABU, asymptomatic bacteriuria; UTI, urinary tract infection; ABC, asymptomatic bacteriocholia; BTI, biliary tract infection; GI, gastrointestinal; SBP, spontaneous bacterial
peritonitis; PD, peritoneal dialysis; OD, optical density.
ap <0.0001 vs. faeces; bp <0.05 vs. UTI; cp <0.01 vs. UTI; dp <0.0001 vs. BTI; ep <0.01 vs. faeces; fp <0.05 vs. faeces; gp <0.0001 vs. UTI; hp <0.01 vs. appendicitis/GI perfora-
tion; ip <0.001 vs. faeces; jp <0.05 vs. BTI; kp <0.01 vs. BTI; lp <0.01 vs. appendicitis/GI perforation; mp <0.001 vs. BTI; np <0.001 vs. UTI. . *Results are expressed as medians
and ranges.
TABLE 3. Comparative distribution of phylogenetic groups and virulence factors among isolates of Escherichia coli from faeces
and extra-intestinal colonized and infected sites
Faeces vs.
ABU
Faeces vs.
UTI
Faeces vs.
ABC
Faeces vs.
BTI
Faeces vs.
appendicitis/GI
perforation
Faeces vs.
SBP/PD-related
peritonitis
Phylogenetic groups Similar Similar Different Different Similar Similar
Virulence factors Similar Different Different Different Different Similar
ABU, asymptomatic bacteriuria; UTI, urinary tract infection; ABC, asymptomatic bacteriocholia; BTI, biliary tract infection; GI, gastrointestinal; SBP, spontaneous bacterial
peritonitis; PD, peritoneal dialysis.
‘Different’ deﬁned as a difference in one or more of four phylogenetic groups and in two or more of 14 virulence genes; otherwise, deﬁned as ‘Similar’.
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infection isolates is summarized in Table 3. Similarities in
both phylogenetic group and virulence factor distribution
were found between faeces and ABU isolates, and between
faeces and SBP/PD-related peritonitis isolates.
The distribution of host and bacterial characteristics in
relation to the phylogenetic group is presented in Table 4.
There were no signiﬁcant differences in age, gender and
host-compromising factors among different phylogenetic
groups. Phylogenetic group B2 was associated with a greater
prevalence of papG III, ﬁmH, sfa, iha, hlyA, cnf1, ompT, and
usp. Phylogenetic group D was associated with a greater
prevalence of papG II, ﬁmH, iha, iutA, and ompT. There was
no signiﬁcant difference among the phylogenetic groups with
respect to the capacity for bioﬁlm formation (Table 4) or
antimicrobial resistance (data not shown).
Regarding the bacterial characteristics of E. coli in relation
to the immune status of the host, there were no signiﬁcant
differences with respect to the phylogenetic group and the
capacity for bioﬁlm formation. Immunocompetent, as
opposed to compromised, hosts were associated with a
greater prevalence of papG II, afa, and iha, and with lower
antimicrobial resistance to ﬂuoroquinolone (p 0.0006,
p 0.0403, p 0.0149, and p 0.0146; respectively).
Discussion
This study addresses the important roles of host and bacterial
factors in common E. coli extra-intestinal colonizations (urine
and bile) and infections (UTI, BTI, and peritonitis). In E. coli
extra-intestinal infections, phylogenetic group B2 was pre-
dominant, and the corresponding isolates were more virulent
than those of the three other phylogenetic groups. Not only
are bacteriuria and UTI caused by the entry of E. coli into the
urinary tract, mainly owing to ascending faecal strains, but
the E. coli strains from SBP/PD-related peritonitis probably
originate from the intestinal microbiota of the colon. Both
host and bacterial factors play important roles in the develop-
ment of extra-intestinal E. coli infections. As found in the
present study, they include the host factors of female gender
in ABU and UTI, of diabetes mellitus in ABU, and of liver cir-
rhosis in SBP, and the bacterial factors of phylogenetic
group B2 in ABU, UTI and acute appendicitis/gastrointestinal
perforation and SBP, of phylogenetic group A in ABC, BTI and
PD-related peritonitis, of papG II, iha and iutA in acute appen-
dicitis/gastrointestinal perforation, of iha, iroN, iutA, ompT and
usp in UTI, and of iutA in SBP/PD-related peritonitis.
TABLE 4. Host and bacterial cha-
racteristics in relation to phylo-
genetic group among isolates of
Escherichia coli from extra-
intestinal colonized and infected
sites (n = 251)
Characteristic
Phylogenetic group
A
(n = 61)
B1
(n = 56)
B2
(n = 83)
D
(n = 51)
Age (years) 59 ± 17 63 ± 17 56 ± 21 54 ± 22
Gender (female) 59 48 67 53
Host-compromising factor
Diabetes mellitus 18 13 11 20
Malignancy 16 13 7 16
Liver cirrhosis 13 2a 7 8
Autoimmune disease 2 2 1 2
Any one of the
above factors
41 25 27 41
Adhesin
papG I 0 0 0 0
papG II 16 29 25 33a
papG III 5 23b 17a 2c,d
ﬁmH 77 96b 94b 96b
sfa 2 4 14b,e 2f
foc 7 2 2 0
afa 20 11 18 12
iha 11 5 29a,g 25c
Toxin
hlyA 10 13 24a 6d
cnf1 5 4 17a,e 2d
Siderophore
iroN 25 36 40 25
iutA 39 46 52 69b,e
Miscellaneous
ompT 36 46 77g,h 65b
usp 8 20 76h,i 31b,j
Bioﬁlm formation
OD590 mm*
0.048 (0.000–0.814) 0.054 (0.000–1.526) 0.44 (0.000–0.399) 0.041 (0.000–1.402)
Values are presented as mean ± standard deviation or percentage unless otherwise indicated.
ap <0.05 vs. A; bp <0.01 vs. A; cp <0.01 vs. B1; dp <0.01 vs. B2; ep <0.05 vs. B1; fp <0.05 vs. B2;
gp <0.001 vs. B1; hp <0.0001 vs. A; ip <0.0001 vs. B1; jp <0.0001 vs. B2. *Results are expressed as medians
and ranges.
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In a study of commensal E. coli isolates from three popula-
tions (Mali, Croatia, and France) those belonging to phyloge-
netic groups A and B1 were found to be the most common
(40% and 34%, respectively) [33]. Johnson et al. [34] showed
that phylogenetic group B2 predominated among faecal, cys-
titis and pyelonephritis isolates (53%, 45%, and 71%, respec-
tively). The present study reveals that phylogenetic group B2
is the most common group in the Taiwanese population
among commensal isolates of E. coli and among isolates from
extra-intestinal infections. The distribution of phylogenetic
groups of E. coli among isolates from the biliary tract and
peritonitis has not previously been assessed. This study
showed predominantly phylogenetic group B2 among isolates
from ABU, UTI, appendicitis/gastrointestinal perforation and
SBP. Phylogenetic group A was most common among iso-
lates from ABC and PD-related peritonitis, whereas phyloge-
netic groups A and B1 were the most common groups
among the isolates from BTI. A greater prevalence of viru-
lence genes (for adhesins, toxins, siderophores, and miscella-
neous factors) in phylogenetic group B2 may explain the
higher frequency of this group among most E. coli isolates
from extra-intestinal colonizations and infections observed in
this study.
An ascending route has been proposed as the major
pathway of E. coli causing UTI and BTI [35–38]. In addition
to the various virulence factors of microorganisms, host
factors such as obstructions and immunocompromising con-
ditions can favour the development of UTI or BTI [3,36].
The entry of E. coli into the peritoneal space from the gas-
trointestinal lumen, resulting in peritonitis, can be the con-
sequence of a defect in, or disruption of, the
gastrointestinal barrier. Overgrowth of intestinal microor-
ganisms, transmural migration and impairment of the hepa-
tic reticuloendothelial system are the proposed mechanisms
for SBP [3,23,39,40]. However, the complete roles of host
and bacterial factors involved in the development of UTI,
BTI and peritonitis remain to be investigated. In this study,
it was found that female gender, diabetes mellitus and
malignancy were more commonly associated with ABU and
UTI. Liver cirrhosis was undoubtedly associated with SBP.
Host-compromising factors were more common in the
ABU, UTI and SBP/PD-related peritonitis groups. A greater
prevalence of papG II was found in isolates from the acute
appendicitis/gastrointestinal perforation group (55%) than in
those from the UTI group (24%).
Studies concerning the virulence factors of E. coli isolates
from populations similar to those studied here are rare, and
have shown that papG II is closely associated with upper
UTI [24,41,42]. The lower prevalence of papG II in the UTI
group isolates (24%) found in this study, similar to that in
the ABU group (16%), may be due to the predominance of
lower UTI isolates (76%) in the UTI group (Table 2).
Similarities in both phylogeny and virulence factors of
E. coli isolates from different sources provide a clue to their
origin. The present results support the current paradigm
concerning the pathogenesis of bacteriuria and UTI, namely
that the E. coli organisms entering the urinary tract are
mainly ascending faecal strains. As compared to E. coli strains
colonizing the urinary bladder, many virulence factors are
necessary for E. coli strains to induce UTI and upper UTI.
Here, we propose that E. coli isolates from SBP/PD-related
peritonitis originate from the intestinal microbiota of the
colon, a lower intestinal segment with similar faecal strains.
With respect to the E. coli isolates from ABC and BTI, the
most probable origin was the duodenum, from where the
intestinal ﬂora can migrate to the biliary tract. This study
showed that the phylogenetic and virulence factor proﬁles
differed between the strains of the faecal and ABC/BTI
groups, which is compatible with the current hypothesis of
the pathogenesis of bacteriocholia and BTI [36].
The role of bioﬁlm formation in the pathogenesis and clin-
ical features of various E. coli infections has been established
[16,30]. However, the capacity for bioﬁlm production was
not associated with any clinical characteristic in a study of
E. coli bacteraemia [21]. In the present study, the role of
microbial bioﬁlm production in causing extra-intestinal colo-
nization or infection was found to be negligible.
Host-compromising factors were associated with a rela-
tively low prevalence of papG II, afa, and iha, but they were
associated with a greater prevalence of bacterial resistance
to ﬂuoroquinolones, without relation to phylogenetic groups
or the capacity for bioﬁlm formation. Both host factors and
bacterial virulence factors can contribute to the development
of colonization and infection with E. coli. A less virulent strain
can colonize a compromised host and even cause infection.
Also, a compromised host is likely to be more frequently
infected and to receive antimicrobial therapy, which can lead
to the development of antimicrobial resistance.
In conclusion, the present study demonstrates that phylo-
genetic group B2 was predominant and more virulent in
most cases of E. coli extra-intestinal colonization and infec-
tion in the Taiwanese population studied here. The host fac-
tors (i.e. age, gender, and host-compromising factors) and
bacterial factors (i.e. phylogenic group and virulence factors),
and their patterns of distribution, were important and quite
diverse; they played different roles in different types of
extra-intestinal colonization and infection. The mechanisms
responsible for the effects of the variable sets of E. coli fac-
tors displayed in the various host populations and infections
need further investigation.
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